scholarly journals External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Samaneh Asgari ◽  
Fatemeh Moosaie ◽  
Davood Khalili ◽  
Fereidoun Azizi ◽  
Farzad Hadaegh
Keyword(s):  
Risk Assessment ◽  
Metabolic Disorders ◽  
Assessment Tool ◽  
Middle Eastern ◽  
External Validation ◽  
Risk Assessment Tool ◽  
Eastern Population ◽  
Middle Eastern Population

scholarly journals External validation of the European risk assessment tool for Chronic Cardio-metabolic disorders in a Middle Eastern population

2020 ◽  
Author(s):  
Samaneh Asgari ◽  
Fatemeh Moosaie ◽  
Davood Khalili ◽  
Fereidoun Azizi ◽  
Farzad Hadaegh
Keyword(s):  
Cardiovascular Disease ◽  
Risk Assessment ◽  
Metabolic Disorders ◽  
Assessment Tool ◽  
External Validation ◽  
Multivariable Analysis ◽  
Iranian Population ◽  
Risk Assessment Tool ◽  
Goodness Of Fit Test

Abstract Background: High burden of chronic cardio-metabolic disorders including type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and cardiovascular disease (CVD) have been reported in the Middle East and North Africa region. We aimed to externally validate a non-laboratory risk assessment tool for the prediction of the chronic cardio-metabolic disorders in the Iranian population. Methods: The predictors included age, body mass index, waist circumference, use of antihypertensive, current smoking, and family history of cardiovascular disease and/or diabetes. For external validation of the model in the Tehran lipids and glucose study (TLGS), the Area under the curve (AUC) and the Hosmer-Lemeshow (HL) goodness of fit test were performed for discrimination and calibration, respectively. Results: Among 1310 men and 1960 women aged 28-85 years, 29.5% and 47.4% experienced chronic cardio-metabolic disorders during the 6 and 9-year follow-up, respectively. The model showed acceptable discrimination, with an AUC of 0.72(95% CI: 0.69-0.75) for men and 0.73(95% CI: 0.71-0.76) for women. The calibration of the model was good for both genders (min HL P=0.5). Considering separate outcomes, AUC was highest for CKD (0.76(95% CI: 0.72-0.79)) and lowest for T2DM (0.65(95% CI: 0.61-0.69)), in men. As for women, AUC was highest for CVD (0.82(95% CI: 0.78-0.86)) and lowest for T2DM (0.69(95% CI: 0.66-0.73)). The 9-year follow-up demonstrated almost similar performances compared to the 6-year follow-up. Using Cox regression in place of logistic multivariable analysis, model’s discrimination and calibration were reduced for prediction of chronic cardio-metabolic disorders; the issue which had more effect on the prediction of incident CKD among women. Moreover, adding data of educational levels and marital status did not improve, the discrimination and calibration in the enhanced model.Conclusion: This model showed acceptable discrimination and good calibration for risk prediction of chronic cardio-metabolic disorders in short and long-term follow-up in the Iranian population.

scholarly journals External validation of the European risk assessment tool for cardio metabolic disease in a Middle Eastern population

2020 ◽  
Author(s):  
Samaneh Asgari ◽  
Fatemeh Moosaie ◽  
Davood Khalili ◽  
Fereidoun Azizi ◽  
Farzad Hadaegh
Keyword(s):  
Metabolic Disease ◽  
Cardiovascular Disease ◽  
Risk Assessment ◽  
Goodness Of Fit ◽  
Assessment Tool ◽  
External Validation ◽  
Iranian Population ◽  
Risk Assessment Tool ◽  
Goodness Of Fit Test

Abstract Background: High burden of chronic cardio-metabolic disease (CCD) including type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and cardiovascular disease (CVD) have been reported in the Middle East and North Africa region. We aimed to externally validate a Europoid risk assessment tool designed by Alssema et al, including non-laboratory measures, for the prediction of the CCD in the Iranian population. Methods: The predictors included age, body mass index, waist circumference, use of antihypertensive, current smoking, and family history of cardiovascular disease and or diabetes. For external validation of the model in the Tehran lipids and glucose study (TLGS), the Area under the curve (AUC) and the Hosmer-Lemeshow (HL) goodness of fit test were performed for discrimination and calibration, respectively. Results: Among 1310 men and 1960 women aged 28-85 years, 29.5% and 47.4% experienced CCD during the 6 and 9-year follow-up, respectively. The model showed acceptable discrimination, with an AUC of 0.72(95% CI: 0.69-0.75) for men and 0.73(95% CI: 0.71-0.76) for women. The calibration of the model was good for both genders (min HL P=0.5). Considering separate outcomes, AUC was highest for CKD (0.76(95% CI: 0.72-0.79)) and lowest for T2DM (0.65(95% CI: 0.61-0.69)), in men. As for women, AUC was highest for CVD (0.82(95% CI: 0.78-0.86)) and lowest for T2DM (0.69(95% CI: 0.66-0.73)). The 9-year follow-up demonstrated almost similar performances compared to the 6-year follow-up. Conclusion: This model showed acceptable discrimination and good calibration for risk prediction of CCD in short and long-term follow-up in the Iranian population.

Accuracy of a fracture risk assessment tool in Iranian osteopenic and osteoporotic women

2016 ◽  
Vol 1 (1) ◽  
pp. 15-19 ◽  
Author(s):  
Arman Ahmadzadeh ◽  
Tahere Sabaghian ◽  
Mina Ebrahimi-Rad ◽  
Mohammad Moslemizadeh ◽  
Mohammad Mehdi Emam ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Fracture Risk ◽  
Assessment Tool ◽  
Fracture Risk Assessment ◽  
Risk Assessment Tool ◽  
Fracture Risk Assessment Tool
Sign in / Sign up

Export Citation Format

Share Document